Evidence map›Paper›PMID 40044711›Full record

ArticleScientific reports2025

An effective MRI perfusion threshold based workflow to triage additional

Krishna Ranjith Kadali, Nathalie Nierobisch, Fabienne Maibach, Philip Heesen, Paula Alcaide-Leon, Martin Hüllner, Michael Weller, Zsolt Kulcsar, Nicolin Hainc

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Krishna Ranjith KadaliUniversity of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0006-7078-2599
Nathalie NierobischDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0005-0992-6867
Fabienne MaibachDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0007-0899-0466
Philip HeesenDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-5090-4935
Paula Alcaide-LeonDepartment of Medical Imaging, University of Toronto, Toronto, Canada.ORCID http://orcid.org/0000-0001-6146-7972
Martin HüllnerDepartment of Nuclear Medicine, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4849-3292
Michael WellerDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-1748-174X
Zsolt KulcsarDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6805-5150
Nicolin HaincDepartment of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland. nicolin.hainc@usz.ch.ORCID http://orcid.org/0000-0003-0916-7387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MRI is the preferred method for follow-up imaging of post-treatment WHO grade 3 or 4 gliomas. While positron emission tomography with O-(2-[

Indexed as

Brain NeoplasmsGliomaMagnetic Resonance ImagingPositron-Emission TomographyTyrosineAdultAgedFemaleHumansMaleMiddle AgedNeoplasm GradingTriageWorkflow(18F)fluoroethyltyrosineTyrosine18F-fluoroethyl-L-tyrosineGliomaPerfusion magnetic resonance imagingPositron-emission tomography

Identifiers

PMID40044711
PMCPMC11882894

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.